Order Article Reprints

Fastner G, Reitsamer R, Gaisberger C, Hitzl W, Urbański B, Murawa D, Matuschek C, Budach W, Ciabattoni A, Reiland J, et al. Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459). Cancers. 2022; 14(6):1396. https://doi.org/10.3390/cancers14061396

Fastner, Gerd, Roland Reitsamer, Christoph Gaisberger, Wolfgang Hitzl, Bartosz Urbański, Dawid Murawa, Christiane Matuschek, Wilfried Budach, Antonella Ciabattoni, Juliann Reiland, and et al. 2022. "Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)" Cancers 14, no. 6: 1396. https://doi.org/10.3390/cancers14061396

Fastner, G., Reitsamer, R., Gaisberger, C., Hitzl, W., Urbański, B., Murawa, D., Matuschek, C., Budach, W., Ciabattoni, A., Reiland, J., Molnar, M., Vidali, C., Schumacher, C., Sedlmayer, F., & on behalf of the HIOB Trialist Group. (2022). Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459). Cancers, 14(6), 1396. https://doi.org/10.3390/cancers14061396